Homocysteine as a risk factor for atherosclerosis: is its conversion to s-adenosyl-L-homocysteine the key to deregulated lipid metabolism?
about
Lipid droplets and peroxisomes: key players in cellular lipid homeostasis or a matter of fat--store 'em up or burn 'em down.Hyperhomocysteinemia-Induced Monocyte Chemoattractant Protein-1 Promoter DNA Methylation by Nuclear Factor-κB/DNA Methyltransferase 1 in Apolipoprotein E-Deficient Mice.Intra-operative grading of coronary artery atherosclerosis associated with homocysteine levels in postmenopausal women undergoing elective off-pump CABG surgery.Plasma and Aorta Biochemistry and MMPs Activities in Female Rabbit Fed Methionine Enriched Diet and Their Offspring.S-adenosyl-L-homocysteine hydrolase and methylation disorders: yeast as a model system.New criteria for supplementation of selected micronutrients in the era of nutrigenetics and nutrigenomics.Atherogenesis: hyperhomocysteinemia interactions with LDL, macrophage function, paraoxonase 1, and exercise.Protective effects of genistein in homocysteine-induced endothelial cell inflammatory injury.Serum metabolomics in a Helicobacter hepaticus mouse model of inflammatory bowel disease reveal important changes in the microbiome, serum peptides, and intermediary metabolism.Homocysteine pre-treatment increases redox capacity in both endothelial and tumor cells.Interactions Between Nuclear Receptor SHP and FOXA1 Maintain Oscillatory Homocysteine Homeostasis in Mice.Effects of folic acid supplementation on serum homocysteine levels, lipid profiles, and vascular parameters in post-menopausal Korean women with type 2 diabetes mellitusPhospholipid methylation controls Atg32-mediated mitophagy and Atg8 recyclingIntegrated analysis, transcriptome-lipidome, reveals the effects of INO-level (INO2 and INO4) on lipid metabolism in yeast.Physical Exercise Is a Potential "Medicine" for Atherosclerosis.Betaine in Inflammation: Mechanistic Aspects and Applications.
P2860
Q30425235-4FBE465D-DF49-4365-B66D-9A07AEDA5994Q36750326-0C5C93E8-2B4F-43ED-BC8A-D7C946B1B8F5Q36806146-957D15C8-6F7D-4508-9D39-3B70687FA1CFQ37590874-B53254B0-48D6-4FE6-A09E-7A6C90366807Q38047086-860EB2B5-13D6-4DDD-9368-A8E370B53E2BQ38195644-97D58495-57B5-4F7C-9A90-2E0230F0D70FQ38724228-EBE65B30-166B-431E-9588-E5A57CF61D7CQ38915886-EC379596-DB44-40B9-88FD-32520054680FQ39742426-F7F99245-4505-4CBA-B939-CFD036389FA8Q39751865-1F15F771-278D-4BDD-BF7C-1020405CF3FFQ39951086-4B4B6E48-7915-4F0C-88CC-194B48C640E5Q41193444-9EDEC692-0AE3-4C2A-8B2E-1C69A3B39D16Q41937023-02D7907F-3ECC-41C8-AE83-8A7F51CD4D6AQ42132235-A65ABFF7-E365-4394-B287-898EE9E1C632Q50096397-BB9C54A0-FC34-4F09-9328-018E1EB671CAQ55016760-51009EC1-B0AE-4B4E-9845-DEDD894241D4
P2860
Homocysteine as a risk factor for atherosclerosis: is its conversion to s-adenosyl-L-homocysteine the key to deregulated lipid metabolism?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Homocysteine as a risk factor ...... deregulated lipid metabolism?
@en
Homocysteine as a risk factor ...... deregulated lipid metabolism?
@nl
type
label
Homocysteine as a risk factor ...... deregulated lipid metabolism?
@en
Homocysteine as a risk factor ...... deregulated lipid metabolism?
@nl
prefLabel
Homocysteine as a risk factor ...... deregulated lipid metabolism?
@en
Homocysteine as a risk factor ...... deregulated lipid metabolism?
@nl
P2860
P921
P356
P1433
P1476
Homocysteine as a risk factor ...... deregulated lipid metabolism?
@en
P2093
Oksana Tehlivets
P2860
P304
P356
10.1155/2011/702853
P577
2011-08-01T00:00:00Z